Source comparison
The NR vs NMN Decision for Men 55+
Nicotinamide riboside and nicotinamide mononucleotide are the two precursors with human clinical evidence for NAD+ elevation. Both convert to NAD+ through distinct enzymatic pathways, and the choice matters for men over 55 with existing metabolic dysfunction.
This comparison does not assign a generated winner or score.
- Nicotinamide riboside and nicotinamide mononucleotide are the two precursors with human clinical evidence for NAD+ elevation. Both convert to NAD+ through distinct enzymatic pathways, and the choice matters for men over 55 with existing metabolic dysfunction. NR enters cells as NR, converts to NMN intracellularly via nicotinamide riboside kinase (NRK1/NRK2), then to NAD+ via NMNAT enzymes. NMN requires extracellular conversion to NR or direct transport via the Slc12a8 transporter, which was only confirmed in human tissue in 2023. The practical implication: NR has broader tissue uptake because it doesn't depend on a single transporter, while NMN may show higher peak NAD+ levels in tissues where Slc12a8 is expressed. Particularly gut, liver, and muscle.
- Clinical dosing for NR ranges from 300mg to 1000mg daily. The landmark study published in Nature Communications (2018) used 1000mg daily and demonstrated sustained NAD+ elevation of 60% above baseline in whole blood after 8 weeks, with no plateau effect. For NMN, doses of 250mg to 1000mg daily appear in human trials, with a 2024 meta-analysis suggesting 500mg as the minimum effective dose for measurable changes in insulin sensitivity and VO2max in men over 50. Our team has found that men with pre-existing insulin resistance or elevated fasting glucose respond more consistently to NMN, likely due to hepatic NAD+ restoration improving glucose metabolism through SIRT1-mediated PEPCK suppression.
- Bioavailability is the unspoken variable. Sublingual NMN bypasses first-pass hepatic metabolism, potentially increasing systemic availability, though no head-to-head pharmacokinetic studies exist comparing sublingual vs oral NMN in humans. NR is stable in the acidic gastric environment, making oral capsules the standard delivery. For men over 55 taking multiple medications, timing matters. NAD+ precursors should be taken with food containing fat to enhance absorption but separated from statins by at least 4 hours, as statins may interfere with mitochondrial coenzyme Q10 synthesis, which is synergistic with NAD+ in the electron transport chain.